Philadelphia Endocrine Society
Donations deductibleRevenue
$212k
year to 31 December 2025
Expenses
$117k
year to 31 December 2025
Total assets
$749k
$0 liabilities
Net assets
$749k
assets less liabilities
Directors and trustees
3
7.4 years on average
Staff
0
employees, year to 31 December 2025
Left since last filing
0
no seats appear to have opened
Officers and senior staff
5
named in Part VII
Philadelphia Endocrine Society's network
3 peoplei3 people on this map.The large node is the subject of this page. Solid lines are what the register itself records (3). Form 990 filings give names without a person identifier; SEC insider filings carry a CIK.The board
3 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 3 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Ajay Rao | President | 2019 | 7 yrs |
| Daniel Rosenbaum | Treasurer | 2018 | 8 yrs |
| Vincent Savarese | Vice President | 2020 | 6 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
5 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Daniel Rosenbaum | Treasurer | since 2021 |
| Pankaj Sharda | Vice President | since 2021 |
| Patrick Hanley | Vice President | since 2022 |
| Samir Panvelker | Vice President | 2023 |
| Vincent Savarese | President | 2021 |
Pay and hours
year to 31 December 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| R Benson Jones Jr | Vice President | 1 | $0 | ||
| Marissa Kilberg | President | 1 | $0 | ||
| Daniel Rosenbaum | Treasurer | 1 | $0 |
No pay was reported for anyone in Part VII on this return.
About
- Legal name
- Philadelphia Endocrine Society
- EIN
- 200106268
- Address
- 1 Market St Apt 617, Camden, NJ, 08102-2323
- State
- New Jersey
- Mission
- To advance the health and understanding of the human endocrine system. (as filed on the Form 990)
- Activity (NTEE)
- E70 Health care
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Health Care
- Size band
- 5 (IRS master file code)
- Principal officer
- Daniel Rosenbaum (as named on the Form 990)
- IRS ruling date
- 1 June 2004
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 3, latest 2020
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥8years on the filingsDaniel Rosenbaum
≥7years on the filingsAjay Rao
≥6years on the filingsVincent Savarese
Latest return
year to 31 December 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2025. US dollars, as filed.- Total assets
- $749k
- Total liabilities
- $0
- Net assets or fund balances
- $749k
- Contributions and grants received
- $190k
- Program service revenue
- $0
- Employees
- 0